CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Equity at beginning of the period at Dec. 31, 2023	$ 165,051	$ 269	$ 509,448	$ (344,667)
Equity at beginning of the period (in shares) at Dec. 31, 2023		269,359
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,296)			(25,296)
Share-based compensation and issuance for vested awards	1,126	$ 0	1,126
Share-based compensation and issuance for vested awards (in shares)		7
Equity at end of the period at Mar. 31, 2024	140,881	$ 269	510,574	(369,963)
Equity at end of the period (in shares) at Mar. 31, 2024		269,366
Equity at beginning of the period at Dec. 31, 2023	165,051	$ 269	509,448	(344,667)
Equity at beginning of the period (in shares) at Dec. 31, 2023		269,359
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(97,472)
Equity at end of the period at Sep. 30, 2024	163,665	$ 298	605,505	(442,138)
Equity at end of the period (in shares) at Sep. 30, 2024		297,644
Equity at beginning of the period at Mar. 31, 2024	140,881	$ 269	510,574	(369,963)
Equity at beginning of the period (in shares) at Mar. 31, 2024		269,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(36,388)			(36,388)
Share-based compensation and issuance for vested awards	600	$ 0	600
Share-based compensation and issuance for vested awards (in shares)		160
Equity at end of the period at Jun. 30, 2024	105,093	$ 270	511,174	(406,351)
Equity at end of the period (in shares) at Jun. 30, 2024		269,526
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35,787)			(35,787)
Issuance of common stock, net	85,187	$ 24	85,163
Issuance of common stock, net (in shares)		23,900
Warrants exchanged for common stock	8,120	$ 3	8,116
Warrants exchanged for common stock (in shares)		3,319
Warrants exercised for common stock	9	$ 1	8
Warrants exercised for common stock (in shares)		900
Share-based compensation	1,044		1,044
Equity at end of the period at Sep. 30, 2024	163,665	$ 298	605,505	(442,138)
Equity at end of the period (in shares) at Sep. 30, 2024		297,644
Equity at beginning of the period at Dec. 31, 2024	123,922	$ 298	606,460	(482,835)
Equity at beginning of the period (in shares) at Dec. 31, 2024		297,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(48,784)			(48,784)
Share-based compensation	1,002		1,002
Equity at end of the period at Mar. 31, 2025	76,141	$ 298	607,462	(531,619)
Equity at end of the period (in shares) at Mar. 31, 2025		297,644
Equity at beginning of the period at Dec. 31, 2024	123,922	$ 298	606,460	(482,835)
Equity at beginning of the period (in shares) at Dec. 31, 2024		297,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(160,336)
Equity at end of the period at Sep. 30, 2025	184,059	$ 348	826,881	(643,171)
Equity at end of the period (in shares) at Sep. 30, 2025		348,305
Equity at beginning of the period at Mar. 31, 2025	76,141	$ 298	607,462	(531,619)
Equity at beginning of the period (in shares) at Mar. 31, 2025		297,644
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(64,685)			(64,685)
Share-based compensation and issuance for vested awards	1,980	$ 0	1,980
Share-based compensation and issuance for vested awards (in shares)		242
Equity at end of the period at Jun. 30, 2025	13,435	$ 298	609,442	(596,304)
Equity at end of the period (in shares) at Jun. 30, 2025		297,887
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(46,866)			(46,866)
Issuance of common stock, net	217,401	$ 47	217,353
Issuance of common stock, net (in shares)		47,423
Warrants exercised for common stock	3	$ 3
Warrants exercised for common stock (in shares)		2,995
Share-based compensation	86		86
Equity at end of the period at Sep. 30, 2025	$ 184,059	$ 348	$ 826,881	$ (643,171)
Equity at end of the period (in shares) at Sep. 30, 2025		348,305